San Francisco, United States
Multiply Labs, founded in 2016 and headquartered in the United States, is at the forefront of combining advanced robotics with the pharmaceutical sector. Their slogan, "Developing advanced robotics technology to manufacture next-gen therapies at industrial scale," encapsulates their mission to revolutionize the biotech and pharmaceutical industries through automation.
The company specializes in robotic systems designed to produce next-generation therapies efficiently and at scale. Emphasizing their commitment to innovation, Multiply Labs has collaborated with leaders in both the pharmaceutical and biotech sectors. Their alliances with respected institutions like UCSF and Stanford for peer-reviewed studies reflect a strong foundation in research and validation.
Their most recent funding, a $20.00M Series A investment on 01 April 2021, was led by notable investors including Founders Fund, Lux Capital, Casdin Capital, Fifty Years, and Garage Capital. These investors bolster Multiply Labs' capacity to scale and further innovate in the biotechnology and automation fields.
